Current Issue Accepted Archive Most Read Most Download
  15 March 2024, Volume 36 Issue 3 Previous Issue   
For Selected: View Abstracts Toggle Thumbnails
Original Article Clinical Research
Effect of perioperative blood pressure variability on post-liver transplant acute kidney injury
XU Lei, ZHANG Tao, CAO Lin, ZHOU Bin, DUAN Manlin
Journal of Hepatopancreatobiliary Surgery. 2024, 36 (3): 129-135.   DOI: 10.11952/j.issn.1007-1954.2024.03.001
Abstract     PDF(919KB)
Objective To investigate the influencing factors of post-liver transplant acute kidney injury (post-LT AKI), and to analyze whether intraoperative hypotension and blood pressure variability affect the incidence of post-LT AKI. Methods Recipients who underwent liver transplantation under general anesthesia were selected between Jun. 1, 2013 and May 31, 2023, in Affiliated Jinling Hospital, Medical School of Nanjing University. The general clinical data and intraoperative blood pressure data of the recipients were collected, and the variability of mean arterial pressure (MAP) was assessed in 4 dimensions: standard deviation (SD), coefficient of variation (CV), average real variability (ARV), and variation independent of mean (VIM). Post-LT AKI influence factors were analyzed with univariate and multivariate Logistic regression, column-line plots were constructed with R software, and the predictive effect was assessed with receiver operating characteristic (ROC) curves. Results Post-LT AKI occurred in 162 of 437 subjects, with an incidence rate of 37.07%; the group was categorized into the AKI group (n=162) and the NO-AKI group (n=275) according to whether or not post-LT AKI occurred. Univariate analysis P<0.1 and previous studies noted as independent risk factors were included in multiple Logistic regression, which showed the following: diabetes [OR=2.141, 95%CI 1.267-3.616, P=0.004], ARV [OR=1.149, 95%CI 1.091-1.209, P<0.001], VIM [OR=2.430, 95%CI 1.303-4.533, P=0.005], the accumulative time of MAP less than 65 mmHg [OR=1.051, 95%CI 1.028-1.073, P<0.001], the accumulative area of MAP less than 65 mmHg [OR=1.008, 95%CI 1.004-1.012, P<0.001], and increased intraoperative blood loss [OR=1.017, 95%CI 1.002-1.032, P=0.029] were independent risk factors for post-LT AKI, and increased urinary output [OR=0.935, 95%CI 0.902-0.968, P<0.001] and use of terlipressin [OR=0.582, 95%CI 0.359-0.942, P=0.028] were protective factors for post-LT AKI. The nomogram model constructed with the above influence factors had an area under the ROC curve (AUC) of 0.833, which showed a good fit and consistency. Conclusion The accumulative time and accumulative area of MAP less than 65 mmHg, ARV, and VIM in liver transplantation is significantly associated with post-LT AKI. Perioperative hypotension should be avoided as much as possible and intraoperative hemodynamic stability should be maintained. Preoperative diabetes and increased intraoperative blood loss lead to an increased incidence of post-LT AKI. Increased urinary output, and the use of terlipressin have a certain renoprotective effect.


Related Articles | Metrics
Construction and validation of a preoperative nomogram prediction model for microvascular invasion in small hepatocellular carcinoma
WANG Xi, CHAI Xinqun
Journal of Hepatopancreatobiliary Surgery. 2024, 36 (3): 136-143.   DOI: 10.11952/j.issn.1007-1954.2024.03.002
Abstract     PDF(920KB)
Objective To investigate the risk factors for microvascular invasion (MVI) in small hepatocellular carcinoma (SHCC) and establish a preoperative nomogram prediction model, and assess the accuracy of it. Methods A retrospective analysis was conducted on the clinical data of 288 patients who underwent hepatectomy due to SHCC at the Affiliated Union Hospital of Tongji Medical College, Huazhong University of Science and Technology from Aug. 2018 to Aug. 2023. Based on the postoperative pathological results, they were divided into MVI positive group (n=96) and MVI negative group (n=192). The general data, serological indicators, inflammatory factors, preoperative imaging data and pathological indicators were collected. Lasso regression analysis combined with univariate and multivariate logistic regression analysis were used to explore the main risk factors for MVI in SHCC patients, and establish a preoperative nomogram prediction model. Results Out of 288 SHCC patients, MVI was confirmed in 96(33.3%). The results of multivariate logistic regression analysis showed that the maximum diameter of the tumor, capsule enhancement, AFP≥200 ng/mL, neutrophil/lymphocyte ratio (NLR)≥1.63, and systemic immune inflammation (SII)≥170.86, platelet count (PLT)≥183.0× 109 /L were independent risk factors for MVI in SHCC patients (P<0.05). The area under the curve (AUC) of the preoperative nomogram prediction model was 0.823. The optimal cutoff value of the column chart calculated by the Youden index was 181.3 points. The sensitivity, specificity, positive predictive value, and negative predictive value under the cutoff value were 65.6%, 84.9%, 68.5%, and 83.2%, which showed good discrimination and consistency. Conclusion The preoperative nomogram prediction model based on tumor maximum diameter, capsule enhancement, AFP≥200 ng/mL, NLR≥1.63, SII≥170.86 and PLT≥183.0×109 /L has high predictive value for the risk of MVI in SHCC, and is of great significance for guiding clinical decision-making and improving poor prognosis.


Related Articles | Metrics
Short-term efficacy and safety of hepatic arterial infusion chemotherapy in the treatment of unresectable hepatocellular carcinoma with high-flow hepatic arterioportal shunts
CHEN Yanhui, ZHANG Yubing, YIN Yunqing, SHEN Xinying
Journal of Hepatopancreatobiliary Surgery. 2024, 36 (3): 144-149.   DOI: 10.11952/j.issn.1007-1954.2024.03.003
Abstract     PDF(864KB)
Objective To observe the short-term efficacy and safety of FOLFOX-HAIC in treatment of unresectable hepatocellular carcinoma combined with high-flow hepatic arterioportal shunts (APS). Methods The clinical data of 30 patients with unresectable hepatocellular carcinoma combined with high-flow APS who received FOLFOX-HAIC from Jun. 2020 to Jan. 2023 were retrospectively collected (HAIC group), and the clinical data of 30 patients in the same target population who underwent transcatheter arterial chemoembolization (TACE) during the same period were also collected (TACE group). The APS improvement rate, objective response rate of tumors and adverse reactions were compared between the two groups. Results The HAIC group showed significantly better results in terms of APS improvement rate (83.3% vs 56.7%, χ2 =5.079, P=0.047), objective response rate of tumor lesions (76.7% vs 46.7%, χ2 =5.711, P=0.017) and median progression-free survival (PFS) (9.5 months vs 5.4 months, Log-rank χ2 =10.832, P=0.001) compared to the TACE group. The incidence of thrombocytopenia in postoperative patients was significantly higher in the HAIC group than in the TACE group (P<0.05). On the other hand, the incidence of postoperative patients with increased alanine transaminase and alkaline phosphatase was significantly higher in the TACE group than in the HAIC group (P<0.05). No serious adverse events were observed. Conclusion HAIC is effective and safe treatment option for improving fistulas and controlling tumors in patients with unresectable hepatocellular carcinoma combined with APS.
Related Articles | Metrics
Preoperative risk factors for postoperative liver failure and recurrence in intrahepatic cholangiocarcinoma patients who underwent radical
resection
CHEN Lei, HE Chao, LIU Pan, FU Qiang, LUO Qiankun, ZHANG Hongwei, QIN Tao
Journal of Hepatopancreatobiliary Surgery. 2024, 36 (3): 150-154.   DOI: 10.11952/j.issn.1007-1954.2024.03.004
Abstract     PDF(780KB)
Objective To predict the risk factors of postoperative liver failure and recurrence within 1 year for intrahepatic cholangiocarcinoma (ICC) patients who underwent radical resection based on preoperative clinical factors. Methods The clinical data of patients with ICC who underwent radical resection at the People’s Hospital of Zhengzhou University from Jun. 2017 to Jun. 2022, were retrospectively analyzed. According to the postoperative liver function index, 56 patients were divided into postoperative liver failure group (n=16) and non-liver failure group (n=40); According to the recurrence status within 1 year after radical resection, this 56 patients were divided into recurrence group (n=22) and non-recurrence group (n=34). Univariate analysis was used to explore risk factors for postoperative liver failure and recurrence within 1 year. The area under the receiver operating characteristic (ROC) curve (AUC) of serum creatinine to cystatin ratio (CCR) in predicting ICC recurrence within 1 year and postoperative liver failure were calculated. The value of CCR at the maximum Youden index was considered as the optimal cut-off point. Multivariate Logistic regression analysis was used to explore the independent risk factors for postoperative liver failure and recurrence within 1 year after radical resection. Results Univariate analysis shewed that there was significant difference in CCR between the recurrence group and non-recurrence group [(53.49±3.90) vs (72.46±2.10)], as well as between the liver failure group and non-liver failure group [(54.67±4.49) vs (69.14±2.48)] (all P<0.05). Weight loss≥5 kg, hepatitis virus quantitation≥104 IU/ML, poor tumor differentiation, tumor maximum diameter≥5 cm, multiple tumor number, and lymph node metastasis were relevant factors for recurrence within 1 year after radical resection. Similarly, weight loss≥5 kg, hepatitis virus quantification≥104 IU/mL, tumor maximum diameter≥5 cm, multiple tumor number, and previous history of bile duct disease were identified as relevant factors for postoperative liver failure. ROC curve analysis showed that the AUCs were 0.814 and 0.720 for CCR in predicting recurrence and postoperative liver failure, respectively (all P<0.05); and the optimal cut-off points were 62.34 and 64.82, respectively. Multivariate Logistic regression analysis showed that low CCR (OR=22.357, 95%CI 1.140-438.308), multiple tumor number (OR=27.050, 95%CI 1.029-711.165), lymph node metastasis (OR=18.046, 95%CI 1.029-711.165), and poor tumor differentiation (OR=18.134, 95%CI 1.357-242.359) were independent risk factors for ICC recurrence within 1 year after radical resection. Tumor maximum diameter≥5 cm (OR=8.800, 95%CI 2.373-32.635) was an independent risk factor for liver failure after radical resection. Conclusion For patients with ICC, CCR can be used as a preoperative clinical index to predict postoperative liver failure and recurrence within 1 year after radical resection.


Related Articles | Metrics
Clinical efficacy between LC+LERV and LC+LCBDE in the treatment of gallbladder stones combined with common bile duct stones
CHEN Qing, WANG Chunfei, HE Yan’an, YAN Chao, HE Yonghong
Journal of Hepatopancreatobiliary Surgery. 2024, 36 (3): 155-160.   DOI: 10.11952/j.issn.1007-1954.2024.03.005
Abstract     PDF(749KB)
Objective To compare the clinical efficacy of laparoscopic cholecystectomy (LC) combined with laparo-endoscopic rendezvous (LERV) and LC+laparoscopic common bile duct exploration (LCBDE) in the treatment of gallbladder stones combined with common bile duct stones. Methods A prospective study was conducted in 110 patients with gallbladder stones and common bile duct stones who admitted to Jiangyou People’s Hospital and Weifang People’s Hospital between Dec. 2021 and May 2023. With a random number table method, patients were randomly divided into LC+LERV group (n=54) and LC+LCBDE group (n=56). The surgical success rate, intraoperative bleeding volume, operation time, time of indwelling drainage tube, postoperative complications, hospitalization time and hospitalization costs, pain visual analogue scale (VAS) of the two groups were compared. Results Compared with the LC+LCBDE group, the LC+LERV group had lower surgical success rate (87.04% vs 100.00%, χ2 =7.467, P=0.006), longer operation time [(112.0±15.6)min vs (98.0±21.5)min, t=3.771, P<0.001], and shorter time of indwelling drainage tube [(2.34±0.66)d vs (7.41±12.88)d, t=-2.693, P=0.008], the differences were all statistically significant (P<0.05). There was no statistically significant difference between the two groups in terms of intraoperative bleeding volume and incidence of postoperative complications (P>0.05). There was no statistically significant difference in VAS scores between the two groups before surgery, 6 h and 1 d after surgery, on the day of discharge (P>0.05), but the VAS score 3 d after surgery in the LC+LCBDE group was significantly higher than that in the LC+LERV group (P<0.05). There was no statistically significant difference in hospitalization time between the two groups (P>0.05), but the hospitalization cost in the LC+LERV group was significantly higher than that in the LC+LCBDE group [(25 653.6±3 317.0)yuan vs (17 978.4±2 158.0)yuan, t=14.219, P<0.001]. Conclusion For treatment of gallbladder stones combined with common bile duct stones, LC+LCBDE and LC+LERV have the same safety performance, and LC+LERV has better postoperative comfort. LC+LCBDE is more effective and cost-effective, and LC+LCBDE can be used as a remedial surgery for LC+LERV intubation or stone removal failure.


Related Articles | Metrics
Basic Experiment
Mechanism of silencing cFLIP in severe acute pancreatitis induced lung injury
WANG Baozhi, PENG Heping, ZHANG Fenghua, HUANG Haixia, CHEN Yubin, YANG Xuewei
Journal of Hepatopancreatobiliary Surgery. 2024, 36 (3): 161-167.   DOI: 10.11952/j.issn.1007-1954.2024.03.006
Abstract     PDF(1919KB)
Objective To explore the role and possible mechanism of silencing cellular FLICE-like inhibitory protein (cFLIP) in severe acute pancreatitis (SAP) induced lung injury. Methods Twelve SD rats were randomly divided into the control group, cFLIPL (cFLIPS) siRNA1 group, cFLIPL (cFLIPS) siRNA2 group, and cFLIPL (cFLIPS) siRNA3 group. The cFLIPL siRNA and cFLIPS siRNA with the highest inhibition rate were screened. Fifty SD rats were randomly divided into the sham surgery group, model control group, cFLIP siRNA-NC group, cFLIPS siRNA group, and cFLIPL siRNA group. A SAP model was established by retrograde injection of 3%
sodium taurocholate solution into the pancreatic bile duct. After successful modeling, rats in the cFLIPS siRNA group, cFLIPL siRNA group, and cFLIP siRNA-NC group were injected with corresponding siRNA solution via the tail vein, while the remaining 2 groups were injected with an equal amount of 0.9% NaCl. HE staining was used to detect pathological changes in lung tissue; ELISA was used to detect the content of IL-6, IL-1β and TNF-α; The fully automatic analyzer was used to detect the number of white blood cells and neutrophils in venous blood; Neutrophil apoptosis was detected by flow cytometry; The expression of neutrophil RIP1 and
caspase-8 proteins were detected by Western blotting. Results The cFLIPL siRNA2 group and cFLIPS siRNA1 group showed the most significant interference efficiency, so these 2 groups were selected for subsequent experiments. Compared with the model control group rats, the cFLIPL siRNA group and cFLIPS siRNA group rats showed reduced alveolar structural damage, thinning of alveolar walls, and reduced infiltration of inflammatory cells. Compared with the model control group, the cFLIPL siRNA group and cFLIPS siRNA group showed that the contents of IL-6, IL-1β and TNF-α were significantly decreased, the numbers of white blood cells and neutrophils in venous blood were significantly decreased, the apoptosis rates of neutrophils were significantly increased, the expression levels of cFLIPL, cFLIPS, and RIP1 protein were significantly decreased, and the expression level of caspase-8 protein was significantly increased; the above differences were all statistically significant (P<0.05). Conclusion This experimental study suggests that, targeted silencing of cFLIP may promote neutrophil apoptosis by upregulating the expression of caspase-8 and inhibiting the expression of RIP1, and may reduce the release of inflammatory mediators IL-6, IL-1β and TNF-α, inhibit the neutrophil infiltration in lung tissue, and then alleviate the lung damage induced by SAP.


Related Articles | Metrics
Clinical Experience
Application of the target management nursing intervention model in preoperative oral nutritional supplements for patients with pancreatic cancer
DING Ling, ZHANG Xiaojiao, WANG Feitong, PENG Sheng, ZHAO Huiling, CHEN Mengdi
Journal of Hepatopancreatobiliary Surgery. 2024, 36 (3): 168-171.   DOI: 10.11952/j.issn.1007-1954.2024.03.007
Abstract     PDF(703KB)
Related Articles | Metrics
Application of the critical view of safety in laparoscopic cholecystectomy
LI Dongdong, JIANG Tao
Journal of Hepatopancreatobiliary Surgery. 2024, 36 (3): 172-175.   DOI: 10.11952/j.issn.1007-1954.2024.03.008
Abstract     PDF(893KB)
Related Articles | Metrics
Case Report
Splenic angioleiomyoma: A case report
YANG Peitao, ZHANG Anhong, ZHANG Ruixin, ZHANG Li, XU Jun
Journal of Hepatopancreatobiliary Surgery. 2024, 36 (3): 176-179.   DOI: 10.11952/j.issn.1007-1954.2024.03.009
Abstract     PDF(1113KB)
Related Articles | Metrics
Complete visceral inversion laparoscopic cholecystectomy: A case report
ZHANG Shaobo, YU Renbin
Journal of Hepatopancreatobiliary Surgery. 2024, 36 (3): 180-181.   DOI: 10.11952/j.issn.1007-1954.2024.03.010
Abstract     PDF(763KB)
Related Articles | Metrics
Research Review
Application and prospects of near infrared Ⅰ/Ⅱ fluorescence imaging technology in hepatobiliary and pancreatic surgery
WANG Yi, CHEN Kang, LUO Quanneng, CHENG Wei
Journal of Hepatopancreatobiliary Surgery. 2024, 36 (3): 182-187,192.   DOI: 10.11952/j.issn.1007-1954.2024.03.011
Abstract     PDF(1595KB)
Related Articles | Metrics
Advances in molecular targeted therapy for intrahepatic cholangiocarcinoma
ZHAO Kaifeng, YING Bao, LIU Chenming, LI Jiawei, WU Guo
Journal of Hepatopancreatobiliary Surgery. 2024, 36 (3): 188-192.   DOI: 10.11952/j.issn.1007-1954.2024.03.012
Abstract     PDF(672KB)
Related Articles | Metrics

Please wait a minute...
Comparison of clinical efficacy between primary suture and T-tube drainage after laparoscopic common bile duct exploration PDF (0KB)
TANG Jian-jun, XI Jian-bo, ZHANG Wei-yuan
PDF (0KB)
PDF (0KB)
The prognostic value of Intermediate Stage Score on patients with sub-classification of intermediate-stage hepatocellular carcinoma undergo liver resection and transarterial chemoembolization PDF (0KB)
SHI Zhen-jing, WU Dao-yi, WU Li-li, WANG Shu-ting, ZHENG Bing-ru, LI Cheng, SHI Chang-sheng, YU Xi-xiang
Therapeutic effects of transcatheter arterial chemoembolization combined with radiofrequency ablation in the treatment of advanced primary hepatocellular carcinoma PDF (0KB)
KUANG Yuan-li, WANG Zheng, YANG Zhi-liang, TAN Zhi-ming
2024
Vol.36
No.2 
2024-02-15
pp.65-0
No.1
2024-01-15
pp.1-0
2023
Vol.35
No.12 
2023-12-15
pp.705-0
No.11
2023-11-15
pp.641-701
No.10
2023-10-15
pp.577-640
No.9
2023-09-15
pp.513-576
No.8
2023-08-15
pp.449-512
No.7
2023-07-15
pp.385-448
No.6
2023-06-15
pp.321-384
No.5
2023-05-15
pp.257-320
No.4
2023-04-15
pp.193-256
No.3
2023-03-15
pp.129-192
No.2
2023-02-15
pp.65-128
No.1
2023-01-15
pp.1-64
2022
Vol.34
No.12 
2022-12-15
pp.705-769
No.11
2022-11-15
pp.641-705
No.10
2022-10-15
pp.0-641
No.9
2022-09-15
pp.0-576
No.8
2022-08-15
pp.0-512
No.7
2022-07-15
pp.0-451
No.6
2022-06-15
pp.321-384
No.5
2022-05-15
pp.257-320
No.4
2022-04-15
pp.0-256
No.3
2022-03-15
pp.129-192
No.2
2022-02-15
pp.64-128
No.1
2022-01-15
pp.0-64
2021
Vol.33
No.12 
2021-12-15
pp.0-768
No.11
2021-11-15
pp.641-0
No.10
2021-10-15
pp.577-0
No.9
2021-09-15
pp.513-0
No.8
2021-08-15
pp.449-0
No.7
2021-07-15
pp.385-0
No.6
2021-06-15
pp.321-384
No.5
2021-05-15
pp.257-330
No.4
2021-04-15
pp.193-256
No.3
2021-03-15
pp.129-192
No.2
2021-02-15
pp.65-128
No.1
2021-01-15
pp.1-64
2020
Vol.32
No.12 
2020-12-15
pp.705-768
No.11
2020-11-15
pp.641-704
No.10
2020-10-15
pp.577-640
No.9
2020-09-15
pp.513-576
No.8
2020-08-15
pp.449-513
No.7
2020-07-15
pp.385-448
No.6
2020-06-15
pp.321-384
No.5
2020-05-15
pp.257-320
No.4
2020-04-15
pp.193-256
No.3
2020-03-15
pp.129-192
No.2
2020-02-15
pp.65-128
No.1
2020-01-15
pp.1-65
2019
Vol.31
No.12 
2019-12-15
pp.705-0
No.11
2019-11-15
pp.641-0
No.10
2019-10-15
pp.577-0
No.9
2019-09-07
pp.513-0
No.8
2019-08-07
pp.449-0
No.7
2019-07-05
pp.385-449
No.6
2019-06-27
pp.321-0
No.5
2019-05-22
pp.257-0
No.4
2019-04-24
pp.193-0
No.3
2019-04-09
pp.129-0
No.2
2019-02-22
pp.65-0
No.1
2019-01-01
pp.1-64
2018
Vol.30
No.6 
2018-11-25
pp.441-528
No.5
2018-10-01
pp.353-0
No.4
2018-07-25
pp.265-352
No.3
2018-05-25
pp.177-264
No.2
2018-03-25
pp.89-176
No.1
2018-01-19
pp.1-88
2017
Vol.29
No.6 
2017-11-25
pp.441-0
No.5
2017-09-25
pp.353-0
No.4
2017-07-25
pp.265-352
No.3
2017-05-25
pp.177-264
No.2
2017-03-25
pp.89-176
No.1
2017-01-25
pp.1-88
2016
Vol.28
No.6 
2016-11-25
pp.441-528
No.5
2016-09-25
pp.0-441
No.4
2016-07-25
pp.265-352
No.3
2016-05-25
pp.177-264
No.2
2016-03-25
pp.89-176
No.1
2016-01-25
pp.1-88
2015
Vol.27
No.6 
2015-11-25
pp.441-528
No.5
2015-09-25
pp.353-440
No.4
2015-07-25
pp.265-352
No.3
2015-05-25
pp.177-264
No.2
2015-03-25
pp.89-176
No.1
2015-01-25
pp.1-88
2014
Vol.26
No.6 
2014-11-25
pp.441-528
No.5
2014-09-25
pp.353-440
No.4
2014-07-20
pp.265-352
No.3
2014-05-20
pp.177-264
No.2
2014-03-01
pp.89-176
No.1
2014-01-15
pp.1-88
2013
Vol.25
No.6 
2013-11-25
pp.441-528
No.5
2013-09-25
pp.353-441
No.4
2013-07-25
pp.265-353
No.3
2013-05-25
pp.177-265
No.2
2013-03-25
pp.89-176
No.1
2013-01-25
pp.1-88
2012
Vol.24
No.6 
2012-06-25
pp.441-528
No.5
2012-05-25
pp.353-441
No.4
2012-04-25
pp.265-352
No.3
2012-03-25
pp.177-264
No.2
2012-02-25
pp.103-177
No.1
2012-01-25
pp.1-88
2011
Vol.23
No.6 
2011-11-30
pp.441-525
No.5
2011-10-30
pp.353-441
No.4
2011-07-31
pp.265-352
No.3
2011-05-30
pp.177-265
No.2
2011-03-31
pp.86-177
No.1
2011-01-31
pp.1-86


肝胆胰外科杂志
·
Clinical characteristics and treatment strategies of hepatic inflammatory myofibroblastic tumor
[2023, No.4:219-224] (567)
·
Application of da Vinci Xi robotic system in hepatectomy
[2023, No.4:198-203] (526)
· Predictive factors for textbook outcome after radical resection of perihilar cholangiocarcinoma [2023, No.5:263-267] (429)
· Application of limited anatomical hepatectomy in laparoscopic radical resection for stage T3 gallbladder carcinoma [2023, No.5:268-273] (417)
·
Splenectomy combined with pericardial devascularization for treatment of recurrent rupture and bleeding of esophageal and gastric varices after TIPS: A report of 17 cases
[2023, No.5:295-297] (415)
·
Isolation and characterization of pancreatic islets in db/db mice
[2023, No.4:230-232] (401)
·
Prevention and management of complications druing percutaneous transhepatic choledochoscopy lithotomy for treatment of intrahepatic bile duct stones
[2023, No.4:236-238] (380)
·
Treatment progress on hepatocellular carcinoma with portal vein tumor thrombus
[2023, No.4:252-256] (378)
·
Comparison of prognosis between transarterial chemoembolization synchronously or sequentially combined with microwave ablation in the treatment of hepatocellular carcinoma
[2023, No.4:213-218] (374)
·
The effect of PPI on the treatment of hepatocellular carcinoma with PD-1 inhibitors: PSM analysis combined with Nomogram prediction of the prognosis
[2023, No.4:204-212] (371)
· Value of serum γ-GT and CA199 in prognosis assessment of patients with intrahepatic cholangiocarcinoma after resection [2023, No.6:343-347] (370)
·
Application of laparoscopic choledocholithotomy and primary closure in treatment of choledocholithiasis in elderly patients
[2023, No.4:239-241] (359)
·
The application of fully covered metal stent in biliary and pancreatic diseases
[2023, No.4:193-197] (357)
·
Progress on pathogenesis for cirrhotic portal hypertension
[2023, No.5:311-315] (354)
·
Current status of TACE in treatment of hepatocellular carcinoma and its updates in 2022 BCLC strategy
[2023, No.6:326-330] (351)
·
Application of robot-assisted surgery for treatment of hepatobiliary and pancreatic malignancies
[2023, No.6:321-325,347] (349)
·
Research progress of PARP inhibitors in the treatment of pancreatic cancer and its drug resistance
[2023, No.5:316-320] (341)
·
Anatomical and functional characteristics of peribiliary gland and its pathophysiology in cholangiopathy
[2023, No.7:385-389,396] (332)
·
Intrahepatic sarcomatoid cholangiocarcinoma with focal squamous cell carcinoma: A case report
[2023, No.4:245-247] (323)
·
Postoperative biliary leakage after aortic dissection presenting as persistent hiccup: A case report
[2023, No.4:242-244] (321)
· Braun anastomosis in the treatment of high fever after pancreaticoduodenectomy: A case report [2023, No.6:374-376] (317)
·
Management of bile duct complications during the process of pancreatic head and uncinate resection
[2023, No.4:233-235] (312)
·
Research progress of interventional therapy for pancreatic cancer with liver metastasis
[2023, No.8:507-512] (311)
·
Short-term effect of modified peritoneal priority laparoscopic pancreaticoduodenectomy
[2023, No.5:274-279] (310)
·
Efficacy and safety of splenic artery embolization in treatment of splenic artery steal syndrome after liver transplantation
[2023, No.6:348-352] (310)
· Factors affecting the recovery of patients with mild anemia after laparoscopic liver resection [2023, No.6:337-342] (305)
·
Therapeutic effect of repeat hepatectomy for recurrent liver cancer
[2023, No.7:390-396] (305)
· Relationship between CT value of pancreatic duct stones and therapeutic effect of extracorporeal  shock wave lithotripsy#br# [2023, No.6:361-365] (285)
·
Advances in the role of extracellular vesicular and non-coding RNA in hepatic ischemia-reperfusion injury
[2023, No.7:439-443] (284)
·
Emergency consultation strategy for biliary duct injury during laparoscopic cholecystectomy
[2023, No.7:423-425] (280)
· Expression of VAV gene family in hepatocellular carcinoma and its clinical significance [2023, No.6:366-373] (275)
·
Fixing the anterior wall of stomach greater curvature improves postoperative dietary tolerance in patients undergoing pancreaticoduodenectomy
[2023, No.5:298-301] (275)
·
Application of vascular intervention in the treatment of hepatocellular carcinoma
[2023, No.6:331-336] (274)
· Application of panoramic compound digital laparoscopy in single-incision cholecystectomy [2023, No.6:357-360] (271)
· Application of indocyanine green fluorescence fusion image guided laparoscopic anatomical left  hemihepatectomy through the combined dorsal head and caudal approach#br# [2023, No.6:353-356,365] (270)
·
Application prospects of endoscopic retrograde cholangiopancreatography in acinar-to-ductal metaplasia related disease
[2023, No.7:444-448] (268)
·
Disputes and reflections of lymph node dissection in pancreaticoduodenectomy for pancreatic cancer
[2023, No.8:449-453,458] (267)
·
Clinical risk factors analysis and diagnostic prediction of acute gangrenous cholecystitis
[2023, No.7:401-406] (262)
·
Contribution of coagulation imbalance in development of portal vein thrombosis after splenectomy and esophagogastric devascularization for cirrhotic portal hypertension
[2023, No.4:225-229] (262)
·
Local ablation for hepatocellular carcinoma: System construction and value promotion
[2023, No.5:257-262] (256)

» Two-port laparoscopic common bile duct exploration to treat common bile duct calculi 
  CHEN Chun-hua, CHEN Jun, REN Liu-kui, et al.
  肝胆胰外科杂志. 2015 Vol. 27 (2): 97-98
» Application of multi-detector computed tomography combined with three-dimensional reconstruction in the diagnosis and treatment of hilar cholangiocarcinoma
  NI Qi-hong, ZHANG Yun-he, CHEN Wei, et al
  Journal of Hepatopancreatobiliary Surgery. 2015 Vol. 27 (1): 84-85
» The function and correlative study among ICG-R15, iMELD and CLD score on forecasting post-hepatectomy liver dysfunction for hepatocellular carcinoma
  ZHANG Guan-qi, ZHANG Zhi-wei, LI Chang-hai, et al.
  Journal of Hepatopancreatobiliary Surgery. 2014 Vol. 26 (6): 463-465
» Primary suture of laparoscopic common bile duct exploration after biliary operation : report of 27 cases
  LIU Sheng-yong, CHEN Xue-min, SUN Dong-lin, et al
  肝胆胰外科杂志. 2015 Vol. 27 (1): 63-64
Adv Search
Author Center Office Work
Peer Review Editor Work
News More>>
Journal  
Forthcoming Articles
Current Issue
Archive
Advanced Search
Highlights
Most Read
Most Downloaded
Most Cited
Email Alert
Download More>>
Information  
主管单位:浙江省教育厅
主办单位:温州医科大学
编辑出版:肝胆胰外科杂志编辑部
地址:浙江省温州市茶山高教园区温州医科大学同心楼601室
邮编:325035
电话(传真):0577-86699363
电子信箱:gdywkzz@vip.126.com
网址:https://gdy.qk.wmu.edu.cn
公众微信号:gdywkzz
 
Copyright © 2017 Journal of Hepatopancreatobiliary Surgery All Rights Reserved.
Tel/Fax:0577-86699363 E-mail: gdywkzz@vip.126.com
Powered by Beijing Magtech Co. Ltd